Iradimed Co

Price Chart

Risk-Adjusted Performance

Iradimed Co (IRMD) Price Performance

Iradimed Co (IRMD) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $93.71, up 1.99% from the previous close.

Over the past year, IRMD has traded between a low of $50.36 and a high of $105.15. The stock has gained 82.2% over this period. It is currently 10.9% below its 52-week high.

Iradimed Co has a market capitalization of $1.27B, with a price-to-earnings ratio of 66.13 and a dividend yield of 81.00%.

About Iradimed Co

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.